Home › OXiGENE Inc (OXGN) Stock Rating Lowered by Zacks Investment Research
 

Keywords :   


OXiGENE Inc (OXGN) Stock Rating Lowered by Zacks Investment Research

2015-12-09 09:56:15| Biotech - Topix.net

According to Zacks, "OXiGENE, Inc. is an international biopharmaceutical company engaged principally in research into and the development of products for use in the treatment of cancer and other major diseases. " Separately, HC Wainwright lowered their target price on shares of OXiGENE from $6.00 to $4.00 and set a "buy" rating on the stock in a research note on Friday, October 2nd.

Tags: research rating stock investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Potential Storm Surge Flooding Map
06.10Hurricane Milton Probabilistic Storm Surge Graphics
06.10Hurricane Milton Graphics
06.10Hurricane Milton Forecast Discussion Number 6
06.10Hurricane Milton Wind Speed Probabilities Number 6
06.10Hurricane Milton Public Advisory Number 6
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Hurricane Kirk Graphics
More »